Literature DB >> 23094884

Predictive value of heart rate recovery after exercise testing in addition to brain natriuretic peptide levels in ambulatory patients with nonischemic dilated cardiomyopathy.

Norihiro Shinoda1, Akihiro Hirashiki, Takahiro Okumura, Rie Okamoto, Xian Wu Cheng, Yuji Kono, Kyosuke Takeshita, Sumio Yamada, Toyoaki Murohara.   

Abstract

BACKGROUND: Heart rate recovery (HRR) is related to autonomic function and is a prognostic marker in cardiovascular disease. We sought to investigate the clinical utility of HRR in addition to BNP levels in ambulatory outpatients with nonischemic dilated cardiomyopathy (NICM).
METHODS: Seventy-nine NICM outpatients were followed for a mean of 19 months. HRR was defined as the difference in heart rate between peak exercise and 1 minute later. On the basis of the lower tertile value, we allocated the patients to two groups: with HRR >12 bpm (n = 48; normal) and with HRR ≤12 bpm (n = 31, abnormal).
RESULTS: The probability of cardiac event-free survival was significantly lower in the abnormal HRR group than in the normal HRR group (P = 0.002). Stepwise multivariate analysis revealed that plasma BNP and HRR were independent predictors of cardiac events. Patients with both HRR ≤12 bpm and BNP ≥200 pg/mL had significantly higher rates of cardiac events than those in whom only one, or neither, of these variables was abnormal.
CONCLUSIONS: HRR after exercise testing, in addition to plasma BNP level, might be a useful indicator as a predictor for admission due to worsening heart failure and its combination is able to provide additive prognostic information in ambulatory outpatients with NICM.
© 2012, Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23094884      PMCID: PMC6932126          DOI: 10.1111/j.1542-474X.2012.00542.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  22 in total

1.  Parasympathetic effects on heart rate recovery after exercise.

Authors:  Prince J Kannankeril; Francis K Le; Alan H Kadish; Jeffrey J Goldberger
Journal:  J Investig Med       Date:  2004-09       Impact factor: 2.895

2.  Prognostic value of heart rate recovery in patients with heart failure.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Mary Ann Peberdy
Journal:  Am Heart J       Date:  2006-04       Impact factor: 4.749

3.  Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).

Authors:  Inder S Anand; Lloyd D Fisher; Yann-Tong Chiang; Roberto Latini; Serge Masson; Aldo P Maggioni; Robert D Glazer; Gianni Tognoni; Jay N Cohn
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

4.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

Authors:  K Swedberg; P Eneroth; J Kjekshus; L Wilhelmsen
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

5.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

6.  Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure.

Authors:  H Ishise; H Asanoi; S Ishizaka; S Joho; T Kameyama; K Umeno; H Inoue
Journal:  J Appl Physiol (1985)       Date:  1998-04

Review 7.  Natriuretic peptides.

Authors:  Lori B Daniels; Alan S Maisel
Journal:  J Am Coll Cardiol       Date:  2007-12-18       Impact factor: 24.094

8.  Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure.

Authors:  K Imai; H Sato; M Hori; H Kusuoka; H Ozaki; H Yokoyama; H Takeda; M Inoue; T Kamada
Journal:  J Am Coll Cardiol       Date:  1994-11-15       Impact factor: 24.094

9.  Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.

Authors:  Mototsugu Nishii; Takayuki Inomata; Hitoshi Takehana; Takashi Naruke; Tomoyoshi Yanagisawa; Masahiko Moriguchi; Sadao Takeda; Tohru Izumi
Journal:  J Am Coll Cardiol       Date:  2008-06-17       Impact factor: 24.094

10.  Correlates and prognostic implication of exercise capacity in chronic congestive heart failure.

Authors:  J Szlachcic; B M Massie; B L Kramer; N Topic; J Tubau
Journal:  Am J Cardiol       Date:  1985-04-01       Impact factor: 2.778

View more
  1 in total

Review 1.  Cardiovascular recovery from psychological and physiological challenge and risk for adverse cardiovascular outcomes and all-cause mortality.

Authors:  Vanessa Panaite; Kristen Salomon; Alvin Jin; Jonathan Rottenberg
Journal:  Psychosom Med       Date:  2015-04       Impact factor: 4.312

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.